Taxpayers Against Fraud foresees more than $9 billion in False Claims Act recoveries, “…counting civil, state and criminal fines – is within the realm of possible for FY 2012,” stated Patrick Burns of TAF. The cases settled or lined up for settlement included: Merck ($950 million); GlaxoSmithKline ($3 billion); Abbott ($1.5 billion); Amgen ($780 million); Oracle ($200 million); New York City ($70 million); LHC Groups ($65 million); Pfizer ($500 million); Ranbaxy ($400 million); Sandoz ($150 million); Maxim ($150 million); Johnson & Johnson ($1 billion); Agility/Public Warehouse ($500 million); WellCare Health Plans ($137 million); and Medtronic ($23 million).

For more information see: http://www.corporatecrimereporter.com/taf01092012.htm

This entry was posted on Tuesday, January 17th, 2012 at 10:06 am and is filed under Federal False Claims Act, State False Claims Acts. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.